When gastrointestinal stromal tumour (GIST), the most common form of sarcoma, was first
recognized as a distinct pathological entity in the 1990s, patients with advanced-stage …

Mesenchymal gastrointestinal cancers are represented by the gastrointestinal stromal
tumors (GISTs) which occur throughout the whole gastrointestinal tract, and affect human …

Highlights•This Clinical Practice Guideline provides key recommendations on the
management of soft tissue and visceral sarcomas.•Recommendations have been agreed …

Osteosarcoma is a rare malignancy arising from mesenchymal tissue, and represents the
most common bone sarcoma. The management of osteosarcoma is challenging, and …

Small-bowel tumors represent a rare entity comprising 0.6% of all new cancer cases in the
US, and only 3% of all gastrointestinal neoplasms. They are a heterogenous group of …

Background The long-term impact of tyrosine kinase inhibitor (TKI) discontinuation on
resistance and survival in patients with advanced gastrointestinal stromal tumours (GIST) is …

Simple Summary In the latest WHO classification, solitary fibrous tumors (SFTs) are now
subdivided into benign SFT (intermediate category (locally aggressive)), SFT NOS …

Risk assessment of gastrointestinal stromal tumor (GIST) according to the AFIP/Miettinen
classification and mutational profiling are major tools for patient management. However, the …

Gastric subepithelial lesions (SELs) are intramural lesions that arise underneath the gastric
mucosa. SELs can be benign, but can also be malignant or have malignant potential …

Importance The incidence of gastrointestinal stromal tumors (GISTs) increased after the
implementation of GIST-specific histology coding in 2001, but updated data on trends and …